Joseph Scheeren

Joseph Scheeren, who has a doctorate in pharmacy, is the new president and CEO for Critical Path Institute, known as C-Path. C-Path is an independent, nonprofit organization committed to the improvement of the drug development process. He previously served as a senior adviser for research and development for Bayer AG. Scheeren has spent the past 36 years in the pharmaceutical industry, both domestically and internationally, in drug development and regulatory approval.